4-Bromo-2-fluoro-1-iodobenzene
4-Bromo-2-fluoro-1-iodobenzene is an intermediate. 4-Bromo-2-fluoro-1-iodobenzene can be used in the synthesis of Example 33. 4-Bromo-2-fluoro-1-iodobenzene can be used in lung adenocarcinoma research[1].
Product Specifications
CAS Number
[105931-73-5]
Product Name Alternative
4-Bromo-2-fluoroiodobenzene
UNSPSC
12352200
Hazard Statement
H315, H319, H335
Target
Biochemical Assay Reagents; Drug Intermediate
Type
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/4-bromo-2-fluoro-1-iodobenzene.html
Purity
99.98
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
IC1=C(F)C=C(Br)C=C1
Molecular Formula
C6H3BrFI
Molecular Weight
300.90
Precautions
H315, H319, H335
References & Citations
[1]Martin Duplessis, et al. Compounds. WO2020002487A1. WIPO (PCT) . 2019-06-27.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MAP2K4, phosphorylated (pS257) (EC 2.7.12.2, MAP kinase kinase 4, JNK-activating kinase 1, c-Jun N-terminal kinase kinase 1, JNKK, SAPK/ERK kinase 1, SEK1)
MAP2K4, phosphorylated (pS257) (EC 2.7.12.2, MAP kinase kinase 4, JNK-activating kinase 1, c-Jun N-terminal kinase kinase 1, JNKK, SAPK/ERK kinase 1, SEK1)
DC-SIGN (CD209 Antigen-like Protein A, Dendritic Cell-specific ICAM-3-grabbing Non-integrin, CD209, Cd209a, Cire) (HRP) discontinued